SOHM (SHMN) Payments of Debt: $0.00 Mil (TTM As of . 20)


What is SOHM Payments of Debt?

SOHM SHMN -2.91% Payments of Debt is $0.00 Mil as of . 20.

SOHM's Payments of Debt for the three months ended in . 20 was $0.00 Mil.

SOHM's Payments of Debt for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

SOHM Payments of Debt Related Terms

SOHM Payments of Debt Historical Data

* Premium members only.

The historical data trend for SOHM's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOHM Payments of Debt Chart

SOHM Annual Data
Trend
Payments of Debt

SOHM Quarterly Data
Payments of Debt

SOHM Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $0.00 Mil mean?
SOHM (SHMN) has a Payments of Debt of $0.00 Mil as of . 20. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on SOHM and its competitors.
Is SOHM's Payments of Debt too high?
SOHM's current Payments of Debt is $0.00 Mil.
How does SOHM's Payments of Debt compare to NUVPF and ADMD?
SOHM's Payments of Debt of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Drug Manufacturers company?
A good Payments of Debt depends on the Drug Manufacturers industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on SOHM and its competitors. SOHM's current Payments of Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOHM stock overvalued right now?
SOHM (SHMN) has a current Payments of Debt of $0.00 Mil. The current Payments of Debt is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For SOHM (SHMN), the current Payments of Debt is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SOHM Business Description

Address 4195 Chino Hills Parkway, Suite 675, Chino Hills, CA, USA, 91709
SOHM Inc is a pharmaceutical, cosmeceutical, nutraceutical and biotech manufacturer that produces and markets generic drugs and products for various treatment categories. The products of the company include OTC and RX: Generic CDMO Services, and ABBIE Systems. The organization markets and sells its generic drugs globally but focuses on emerging markets in Africa, Latin America, Southeast Asia, and others.